Why is Mankind Pharma Ltd ?
1
High Management Efficiency with a high ROCE of 23.22%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.58 times
3
Healthy long term growth as Net Sales has grown by an annual rate of 17.71%
4
With a growth in Net Profit of 37.57%, the company declared Very Positive results in Sep 26
- The company has declared positive results for the last 3 consecutive quarters
- OPERATING CF(Y) Highest at Rs 2,751.99 Cr
- OPERATING PROFIT TO INTEREST(Q) Highest at 11.16 times
- PBT LESS OI(Q) Highest at Rs 834.26 cr.
5
Stock is technically in a Bullish range
- The technical trend has improved from Mildly Bullish on 16-Nov-26 and has generated 1.33% returns since then
- The stocks MACD and Bollinger Band technical factors are also Bullish
6
High Institutional Holdings at 24.93%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
How much should you buy?
- Overall Portfolio exposure to Mankind Pharma should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Mankind Pharma for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Mankind Pharma
18.91%
0.66
28.86%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
17.71%
EBIT Growth (5y)
19.92%
EBIT to Interest (avg)
32.15
Debt to EBITDA (avg)
1.33
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
0.77
Tax Ratio
21.04%
Dividend Payout Ratio
2.16%
Pledged Shares
0
Institutional Holding
24.93%
ROCE (avg)
20.02%
ROE (avg)
15.82%
Valuation Key Factors 
Factor
Value
P/E Ratio
47
Industry P/E
40
Price to Book Value
6.25
EV to EBIT
35.56
EV to EBITDA
27.65
EV to Capital Employed
5.52
EV to Sales
7.33
PEG Ratio
1.37
Dividend Yield
NA
ROCE (Latest)
15.51%
ROE (Latest)
13.36%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
No Trend
Technical Movement
22What is working for the Company
OPERATING CF(Y)
Highest at Rs 2,751.99 Cr
OPERATING PROFIT TO INTEREST(Q)
Highest at 11.16 times
PBT LESS OI(Q)
Highest at Rs 834.26 cr.
DPS(Y)
Highest at Rs 1.00
DPR(Y)
Highest at 2.03%
NET SALES(Q)
Highest at Rs 4,337.86 cr
PBDIT(Q)
Highest at Rs 1,171.25 cr.
PAT(Q)
Highest at Rs 711.48 cr.
EPS(Q)
Highest at Rs 17.23
-2What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 7.06 times
Loading Valuation Snapshot...
Here's what is working for Mankind Pharma
Operating Profit to Interest - Quarterly
Highest at 11.16 times and Grown
each quarter in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Operating Cash Flow - Annually
Highest at Rs 2,751.99 Cr and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 834.26 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 834.26 cr has Grown at 41.0% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 591.87 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Net Sales - Quarterly
Highest at Rs 4,337.86 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 1,171.25 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 711.48 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 711.48 cr has Grown at 32.4% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 537.25 CrMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 17.23
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Dividend per Share (DPS) - Annually
Highest at Rs 1.00
in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (Rs)
Dividend Payout Ratio (DPR) - Annually
Highest at 2.03%
in the last five yearsMOJO Watch
Company is distributing higher proportion of profits generated as dividend
DPR (%)
Here's what is not working for Mankind Pharma
Debtors Turnover Ratio- Half Yearly
Lowest at 7.06 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio